|
1
|
Pimple S, Mishra G and Shastri S: Global
strategies for cervical cancer prevention. Curr Opin Obstet
Gynecol. 28:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun Y, Yang X, Liu M and Tang H: B4GALT3
up-regulation by miR-27a contributes to the oncogenic activity in
human cervical cancer cells. Cancer Lett. 375:284–292. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ojesina AI, Lichtenstein L, Freeman SS,
Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio
L, Cibulskis K, Bertelsen B, et al: Landscape of genomic
alterations in cervical carcinomas. Nature. 506:371–375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V and Lee RC: Identification of
microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods
Mol Biol. 265:131–158. 2004.PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saumet A and Lecellier CH: microRNAs and
personalized medicine: Evaluating their potential as cancer
biomarkers. Adv Exp Med Biol. 888:5–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Srivastava SK, Arora S, Averett C, Singh S
and Singh AP: Modulation of microRNAs by phytochemicals in cancer:
Underlying mechanisms and translational significance. BioMed Res
Int. 2015:8487102015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Virant-Klun I, Ståhlberg A, Kubista M and
Skutella T: MicroRNAs: From female fertility, germ cells, and stem
cells to cancer in humans. Stem Cells Int. 2016:39849372016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazar J, Qi F, Lee B, Marchica J,
Govindarajan S, Shelley J, Li JL, Ray A and Perera RJ: MicroRNA 211
functions as a metabolic switch in human melanoma cells. Mol Cell
Biol. 36:1090–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng B, Qu L, Li J, Fang J, Yang S, Cao Z,
Mei Z and Sun X: MiRNA-211 suppresses cell proliferation, migration
and invasion by targeting SPARC in human hepatocellular carcinoma.
Sci Rep. 6:266792016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Lv J, Zhang F, Che H, Liao Q,
Huang W, Li S and Li Y: MicroRNA-211 expression is down-regulated
and associated with poor prognosis in human glioma. J Neurooncol.
133:553–559. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia B, Yang S, Liu T and Lou G: miR-211
suppresses epithelial ovarian cancer proliferation and cell-cycle
progression by targeting Cyclin D1 and CDK6. Mol Cancer. 14:572015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye L, Wang H and Liu B: miR-211 promotes
non-small cell lung cancer proliferation by targeting SRCIN1.
Tumour Biol. 37:1151–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sümbül AT, Göğebakan B, Bayram S, Batmacı
CY and Öztuzcu S: MicroRNA 211 expression is upregulated and
associated with poor prognosis in colorectal cancer: A case-control
study. Tumour Biol. 36:9703–9709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu D, Liu S, Zhang L and Song L: MiR-211
inhibits invasion and epithelial-to-mesenchymal transition (EMT) of
cervical cancer cells via targeting MUC4. Biochem Biophys Res
Commun. 485:556–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bornstein P and Sage EH: Matricellular
proteins: Extracellular modulators of cell function. Curr Opin Cell
Biol. 14:608–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Shi D, Liu X, Fang S, Zhang J and
Zhao Y: Targeting SPARC by lentivirus-mediated RNA interference
inhibits cervical cancer cell growth and metastasis. BMC Cancer.
12:4642012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao ZS, Wang YY, Chu YQ, Ye ZY and Tao
HQ: SPARC is associated with gastric cancer progression and poor
survival of patients. Clin Cancer Res. 16:260–268. 2010.https://doi.org/10.1158/1078-0432.CCR-09-1247
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derosa CA, Furusato B, Shaheduzzaman S,
Srikantan V, Wang Z, Chen Y, Seifert M, Ravindranath L, Young D,
Nau M, et al: Elevated osteonectin/SPARC expression in primary
prostate cancer predicts metastatic progression. Prostate Cancer
Prostatic Dis. 15:150–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Q, Bao S, Maxwell JA, Reese ED,
Friedman HS, Bigner DD, Wang XF and Rich JN: Secreted protein
acidic, rich in cysteine (SPARC), mediates cellular survival of
gliomas through AKT activation. J Biol Chem. 279:52200–52209. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi D, Jiang K, Fu Y, Fang R, Liu XI and
Chen J: Overexpression of SPARC correlates with poor prognosis in
patients with cervical carcinoma and regulates cancer cell
epithelial-mesenchymal transition. Oncol Lett. 11:3251–3258. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang CY, Hua L, Sun J, Yao KH, Chen JT,
Zhang JJ and Hu JH: MiR-211 inhibits cell proliferation and
invasion of gastric cancer by down-regulating SOX4. Int J Clin Exp
Pathol. 8:14013–14020. 2015.PubMed/NCBI
|
|
25
|
Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL
and Xi F: Overexpression miR-211-5p hinders the proliferation,
migration, and invasion of thyroid tumor cells by downregulating
SOX11. J Clin Lab Anal e22293. 2017.
|
|
26
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
An XJ, Li YQ, Qu XY, Zhang J, Zhang LY,
Wang M, Zhu L, Chen SY, Chen HX, Tu YT, et al: Silencing
endothelin-3 expression attenuates the malignant behaviors of human
melanoma cells by regulating SPARC levels. J Huazhong Univ Sci
Technolog Med Sci. 33:581–586. 2013.https://doi.org/10.1007/s11596-013-1162-3
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin ZY and Chuang WL: Genes responsible
for the characteristics of primary cultured invasive phenotype
hepatocellular carcinoma cells. Biomed Pharmacother. 66:454–458.
2012. View Article : Google Scholar : PubMed/NCBI
|
